For example, a small chemical molecule competitive antagonist of CXCR4, AMD3100, was reported for enhanced effect of cytarabine, decreased tumor burden and improved overall survival of AML mice through mobilizing leukemia cells from bone marrow into the peripheral blood17. This evidence concerns the gene CXCR4 and acute myeloid leukemia.